EnteroBiotix LTD

Biotechnology · GLASGOW, X0

BiotechnologySEC Form D

EnteroBiotix LTD filed a Form D with the U.S. Securities and Exchange Commission on April 9, 2026 for a private securities offering.

Incorporated in United Kingdom and based in GLASGOW, X0, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that EnteroBiotix LTD has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Iain BairdDirector
  • Mark BamforthDirector
  • Elmar Josef SchneeDirector
  • James Roger McIlroyExecutive Officer · Director
  • Douglas Campbell ThomsonDirector
  • Strange MelissaExecutive Officer
  • Barnes JamesExecutive Officer

Recently funded in Biotechnology

Other companies that recently filed a Form D

$3.2MRaised

Goldenrod Therapeutics, Inc.

BiotechnologyHOUSTON, TX
May 26, 2026View SEC Form D
$10.0MRaised

Human Biotech, Inc.

BiotechnologyCAMBRIDGE, MA
May 22, 2026View SEC Form D
$1.0MRaised

Optimeos Life Sciences, Inc.

BiotechnologyPRINCETON, NJ
May 22, 2026View SEC Form D
$2.5MRaised

BioStem Technologies, Inc.

BiotechnologyPOMPANO BEACH, FL
May 21, 2026View SEC Form D
$1.6MRaised

Biolexis Therapeutics Inc.

BiotechnologyLEHI, UT
May 20, 2026View SEC Form D
EnteroBiotix LTD raised $5.3M — SEC Form D